The global ketorolac injection market is anticipated to grow at a CAGR of nearly 4.5% during the forecast period (2022-2028). Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and is especially recommended for moderate to severe pain. The major factor expected to drive the market growth is its diversified medicinal use. For […]